EMILY RHOADES: Open Payments
NPI 1205529047 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$880 in 46 payments from 15 companies in 2025. Trend: 2023 $268 · 2024 $1,573 · 2025 $880
Food & beverage: $835Education: $45
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $205 |
| ABBVIE INC. | 11 | $153 |
| AstraZeneca Pharmaceuticals LP | 5 | $96 |
| Otsuka America Pharmaceutical, Inc. | 3 | $93 |
| Exact Sciences Corporation | 4 | $69 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| PFIZER INC. | 2 | $41 |
| Novo Nordisk Inc | 2 | $32 |
| Corium, LLC | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $29 |
Products named: MOUNJARO, REXULTI, QULIPTA, Cologuard Collection Kit, JARDIANCE, FARXIGA, GEMTESA, BREZTRI.
Industry payments across NC — which companies pay providers there.
